Emerald Advisers’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,815
| Closed | -$564K | – | 286 |
|
|
2021
Q3 | $564K | Sell |
16,815
-806
| -5% | -$27K | 0.02% | 186 |
|
|
2021
Q2 | $703K | Hold |
17,621
| – | – | 0.03% | 177 |
|
|
2021
Q1 | $792K | Buy |
+17,621
| New | +$792K | 0.03% | 165 |
|
|
2017
Q4 | – | Sell |
-22,132
| Closed | -$1.12M | – | 254 |
|
|
2017
Q3 | $1.12M | Buy |
+22,132
| New | +$1.12M | 0.05% | 171 |
|
|
2015
Q2 | – | Sell |
-5,337
| Closed | -$321K | – | 348 |
|
|
2015
Q1 | $321K | Sell |
5,337
-165,732
| -97% | -$9.97M | 0.02% | 304 |
|
|
2014
Q4 | $10.6M | Sell |
171,069
-75,685
| -31% | -$4.67M | 0.56% | 59 |
|
|
2014
Q3 | $9.58M | Buy |
246,754
+47,820
| +24% | +$1.86M | 0.57% | 53 |
|
|
2014
Q2 | $6.85M | Buy |
198,934
+22,498
| +13% | +$775K | 0.39% | 90 |
|
|
2014
Q1 | $7.62M | Sell |
176,436
-145,897
| -45% | -$6.3M | 0.43% | 81 |
|
|
2013
Q4 | $12.8M | Buy |
322,333
+16,388
| +5% | +$653K | 0.7% | 43 |
|
|
2013
Q3 | $11.5M | Buy |
305,945
+33,018
| +12% | +$1.24M | 0.65% | 44 |
|
|
2013
Q2 | $7.33M | Buy |
+272,927
| New | +$7.33M | 0.45% | 75 |
|